Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-14-005260
Filing Date
2014-03-27
Accepted
2014-03-27 17:02:59
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K oxfd20140315_10k.htm 10-K 2992968
2 EXHIBIT 4.2 ex4-2.htm EX-4 209332
3 EXHIBIT 4.3 ex4-3.htm EX-4 54459
4 EXHIBIT 4.4 ex4-4.htm EX-4 52678
5 EXHIBIT 10.4 ex10-4.htm EX-10 91742
6 EXHIBIT 10.20 ex10-20.htm EX-10 25513
7 EXHIBIT 10.45 ex10-45.htm EX-10 109953
8 EXHIBIT 23.1 ex23-1.htm EX-23 2704
9 EXHIBIT 31.1 ex31-1.htm EX-31 14810
10 EXHIBIT 31.2 ex31-2.htm EX-31 14604
11 EXHIBIT 32 ex32.htm EX-32 5809
12 img.jpg GRAPHIC 72272
13 oxfd20140315_10kimg005.jpg GRAPHIC 59289
  Complete submission text file 0001437749-14-005260.txt   3757141
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36200 | Film No.: 14722389
SIC: 2835 In Vitro & In Vivo Diagnostic Substances